AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: March 2024 Quarterly Activities Report & Appendix 4C, page-40

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,115 Posts.
    lightbulb Created with Sketch. 130
    You make some valid points.

    If AVE interim results look good in December then BP would start their own trials using TPM alternatives and it would be a race to the FDA finish line.

    Who would bother betting on AVE if BP is barely six months behind?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.